MYC and Miyoshi myopathy: We also demonstrated the clinical relevance in myeloma patients of a shared transcriptional program identified from analysis of Vκ*MYC tumours using publicly available human single-cell and bulk gene expression data sets and showed that targeting this program has anti-MM activity.